{
  "retracted": false,
  "timestamp": 1496275200000,
  "updates": [
    {
      "timestamp": 1585399859985,
      "identifier": {
        "doi": "10.2337/dc17-er06d"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.2337/dc16-1495"
  },
  "publisher": "American Diabetes Association",
  "title": "Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972â€“1980"
}
